We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+4.3%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$192M
AUM Growth
+$59.6M
Cap. Flow
+$64.9M
Cap. Flow %
33.84%
Top 10 Hldgs %
51.67%
Holding
90
New
22
Increased
13
Reduced
5
Closed
18

Top Buys

Rank Stock Value
1
ALIM
Alimera Sciences
ALIM
+$9.7M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$7.39M
3
SGMT icon
Sagimet Biosciences
SGMT
+$6.43M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$6.39M
5
BHVN icon
Biohaven
BHVN
+$5.97M

Top Sells

Rank Stock Value
1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
+$11.7M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$4.23M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$3.57M
4
GRI
GRI Bio
GRI
+$1.7M
5
HRMY icon
Harmony Biosciences
HRMY
+$1.14M

Sector Composition

Rank Sector Weight
1 Healthcare 88.02%
2 Consumer Staples 0.32%
3 Communication Services 0.27%
4 Materials 0.15%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONFOW icon
51
Onfolio Holdings Warrant
ONFOW
$64.5K
$26.7K 0.01%
200,000
– –
PEPLW
52
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$26.1K 0.01%
367,500
– –
NEXRW
53
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$21.4K 0.01%
480,770
– –
NLSPW
54
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$21K 0.01%
200,000
– –
OSAAW
55
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$10.5K 0.01%
150,000
– –
BTMWW
56
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$9.49K 0.01%
+50,000
New +$10.6K
BNCWW
57
CEA Industries Inc Warrant
BNCWW
$9.2K ﹤0.01%
250,000
– –
HCDIZ
58
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIZ
$6.43K ﹤0.01%
650,000
– –
TGVCW
59
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$6.4K ﹤0.01%
200,000
– –
CDTTW
60
CDT Equity Inc Warrant
CDTTW
$1.87M
$4.5K ﹤0.01%
100,000
– –
HCDIW
61
DELISTED
Harbor Custom Development, Inc. Warrant
HCDIW
$4.5K ﹤0.01%
600,000
– –
MOBXW icon
62
Mobix Labs Warrants
MOBXW
$752K
$4.38K ﹤0.01%
150,000
– –
MITAW
63
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$3.61K ﹤0.01%
28,333
– –
SRZNW icon
64
Surrozen Inc Warrant
SRZNW
$8.86K
$3.38K ﹤0.01%
82,233
– –
VSEEW
65
VSEE HEALTH INC WTS 29
VSEEW
$3.31K ﹤0.01%
150,000
– –
CYCUW
66
Cycurion Inc Warrant
CYCUW
$311K
$3.21K ﹤0.01%
100,000
– –
NXLIW
67
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$2.63K ﹤0.01%
105,000
– –
SLNAW
68
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$1.42K ﹤0.01%
101,439
– –
OHAAW
69
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
$1.39K ﹤0.01%
50,000
– –
TCBPW
70
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$393 ﹤0.01%
18,823
– –
BRSHW
71
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$342 ﹤0.01%
14,423
-346,156
-96% -$13.1K
BBIO icon
72
PUT
BridgeBio Pharma
BBIO
$16.5B
– –
-200,000
Closed -$3.44M
KYNB
73
CALL
Kyntra Bio
KYNB
$29.4M
– –
-1,400
Closed -$94.5K
KYNB
74
PUT
Kyntra Bio
KYNB
$29.4M
– –
-680
Closed -$45.9K
IMVT icon
75
Immunovant
IMVT
$8.25B
– –
-35,100
Closed -$793K
1 2
3
4

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Altium Capital Management held 90 positions worth $192M, up 45% from $132M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Altium Capital Management deployed $64.9M of net new capital in Q3 2023, opening 22 new positions and adding to 13 existing holdings. Its largest new stake was Alimera Sciences: 2,934,108 shares worth $9.1M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 92% a quarter earlier, followed by Consumer Staples and Communication Services.

On the sell side, the largest reduction was GRI Bio, an estimated $1.7M trimmed.

  • Altium Capital Management's largest Q3 2023 buy was Alimera Sciences: 2,934,108 shares worth $9.1M.
  • Altium Capital Management added most to Amylyx Pharmaceuticals in Q3 2023, an estimated $7.39M increase.
  • Altium Capital Management's biggest Q3 2023 reduction was GRI Bio, cutting an estimated $1.7M.
  • Altium Capital Management fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $11.7M.
  • Altium Capital Management's ten largest holdings make up 52% of its $192M portfolio in Q3 2023.
  • Altium Capital Management opened 22 new positions and closed 18 in Q3 2023.
  • Altium Capital Management's portfolio value rose 45% quarter-over-quarter to $192M.

Based on Altium Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.